If You Invested in Bristol-Myers Squibb $2PR (BMYMP)
See the BMYMP overviewWhat $1,000 or $10,000 in BMYMP Was Worth at Its Last Close
Real historical value by amount invested and how long before the last close| If you invested | 1 year before | 5 years before | 10 years before | Since Sep 18, 2023 |
|---|---|---|---|---|
| $1,000 | $667 -33% | — | — | $700 -30% |
| $10,000 | $6,673 -33% | — | — | $7,000 -30% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2026-03-18. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results. We start BMYMP on Sep 18, 2023 because the prices we hold from before that date cannot be compared with the later ones, and a return measured across the two would be wrong.
Custom Calculation
Choose your own date and amount for BMYMP$1,000 Investment Over Time
BMYMP vs S&P 500Year-by-Year Returns
BMYMP annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2023Sep 18, 2023 to Dec 28, 2023 | $1,000.00 | $896.00 | -10.4% | -10.4% |
| 2024Dec 28, 2023 to Dec 18, 2024 | $896.00 | $998.89 | +11.5% | -0.1% |
| 2025Dec 18, 2024 to Dec 30, 2025 | $998.89 | $900.00 | -9.9% | -10.0% |
| 2026Dec 30, 2025 to Mar 18, 2026 | $900.00 | $700.00 | -22.2% | -30.0% |
About Bristol-Myers Squibb $2PR
OTC
Frequently Asked Questions
Bristol-Myers Squibb $2PR investment returns
How much was $1,000 invested in Bristol-Myers Squibb $2PR worth at its last close?
If you invested $1,000 in Bristol-Myers Squibb $2PR (BMYMP) 1 year before its last close, on 2025-03-18, your investment was worth $667 on 2026-03-18, a -33.3% price return without dividends, growing at a compounded rate of -33.3% per year (CAGR).
Has Bristol-Myers Squibb $2PR outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare BMYMP performance over available time periods.
For informational and educational purposes only, not investment advice.
